You are here: Industry Insights > ORCHARD THERAPEUTICS

News List

Orchard Therapeutics Expands Leadership Team with Appointments of Head of Corporate Communications and Head of Human Resources b3cnewswire
August 30, 2018
Boston, USA and London, UK, August 29, 2018 / B3C newswire / -- Orchard Therapeutics, a leading commercial-stage company dedicated to transforming the lives of patients with rare diseases through innovative gene therapies, today announced two additions to
Orchard Therapeutics Announces $150 Million Series C Financing to Advance Gene Therapy Pipeline b3cnewswire
August 20, 2018
Proceeds to advance three late-stage programs towards registration, prepare for commercialization and progress the company’s gene therapy platform Boston, USA and London, UK, August 13, 2018 / B3C newswire
Orchard raises $150m to advance gene therapies pharmatimes
August 15, 2018
UK-American biotech Orchard Therapeutics has raised $150 million to fuel development of its gene therapy pipeline.
Orchard Therapeutics raises $150 M to improve Gene Therapy Pipeline biospectrumasia
August 14, 2018
Proceeds to advance three late-stage programs towards registration, prepare for commercialization and progress the company’s gene therapy platform
Orchard Therapeutics Appoints Jon Ellis to Board of Directors b3cnewswire
August 06, 2018
Orchard Therapeutics, a leading commercial-stage biotech company dedicated to transforming the lives of patients with rare diseases through innovative gene therapies, today announced the appointment of Jon Ellis, Ph.D. as GSK’s designated representative t
Orchard Therapeutics Appoints Joanne Beck, Ph.D. to Board of Directors b3cnewswire
July 24, 2018
Orchard Therapeutics, a leading commercial-stage biotech company dedicated to transforming the lives of patients with rare diseases through innovative gene therapies, today announced the appointment of Joanne Beck, Ph.D., to its board of directors. Dr. B
Orchard Therapeutics Appoints Jim Geraghty as Chairman of its Board of Directors b3cnewswire
July 04, 2018
Orchard Therapeutics, a leading commercial-stage biotech company dedicated to transforming the lives of patients with rare diseases through innovative gene therapies
Orchard Therapeutics announces $110M Series B Financing biospectrumasia
December 25, 2017
In conjunction with the financing, Simone Song, senior partner at ORI Capital has been appointed to Orchard's board of directors
Orchard Therapeutics Announces $110M Series B Financing to Advance Transformative Gene Therapy Pipel b3cnewswire
December 21, 2017
Orchard Therapeutics, a biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies, today announced the completion of an oversubscribed $110 million (£85 million) Series B financing.
Orchard Therapeutics and Généthon Announce Gene Therapy Alliance in X-linked Chronic Granulomatous D b3cnewswire
December 18, 2017
Orchard Therapeutics ("Orchard") today announced a strategy to align with Généthon to develop X-linked chronic granulomatosis gene therapy ("X-CGD")

Previous page 1 2 3 Next page